Growing community of inventors

Framingham, MA, United States of America

Nabeel Bardeesy

Average Co-Inventor Count = 3.50

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Nabeel Bardeesy ↔ Ralph Weissleder (3 patents)Nabeel Bardeesy ↔ Kimberly A Kelly (3 patents)Nabeel Bardeesy ↔ Pasi Antero Janne (1 patent)Nabeel Bardeesy ↔ Kwok-kin Wong (1 patent)Nabeel Bardeesy ↔ Bruce E Johnson (1 patent)Nabeel Bardeesy ↔ Norman E Sharpless (1 patent)Nabeel Bardeesy ↔ Diego H Castrillon (1 patent)Nabeel Bardeesy ↔ Hongbin Ji (1 patent)Nabeel Bardeesy ↔ Kimberly Kelly (1 patent)Nabeel BardeesyNabeel Bardeesy (4 patents)Ralph WeisslederRalph Weissleder (60 patents)Kimberly A KellyKimberly A Kelly (11 patents)Pasi Antero JannePasi Antero Janne (32 patents)Kwok-kin WongKwok-kin Wong (17 patents)Bruce E JohnsonBruce E Johnson (8 patents)Norman E SharplessNorman E Sharpless (4 patents)Diego H CastrillonDiego H Castrillon (2 patents)Hongbin JiHongbin Ji (1 patent)Kimberly KellyKimberly Kelly (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The General Hospital Corporation (4 from 2,893 patents)

2. The University of Texas System (1 from 5,450 patents)

3. The University of North Carolina at Chapel Hill (1 from 1,271 patents)

4. Dana-farber-cancer Institute Inc. (1 from 1,209 patents)


4 patents:

1. 11009508 - Methods of diagnosing and prognosing lung cancer

2. 10124077 - Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma

3. 9387265 - Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma

4. 8829159 - Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…